Sommaire

• • ·Editorial board

    Page :i

    

• Editorial

  • ·“Draw me a…vulva”

    Page :207-208

    C. Fite

    Plan Plan

• Comment

  • ·Venous ulcer healing: Considerations for an optimal protocol

    Page :209-210

    A.-A. Ramelet

    Plan Plan

• Review

  • ·Cutaneous drug-induced lupus erythematosus: Clinical and immunological characteristics and update on new associated drugs

    Page :211-220

    P. Bataille, F. Chasset, J.-B. Monfort, T. De Risi-Pugliese, A. Soria, C. Francès, A. Barbaud, P. Senet

    Résumé Résumé Plan Plan

• Original article

  • ·Vulvar Fordyce adenitis: A cohort of 45 women

    Page :221-227

    F. Poizeau, F. Plantier, H. Bell, M. Moyal-Barracco

    Résumé Résumé Plan Plan  
  • ·Evaluation of timolol maleate gel for management of hard-to-heal chronic venous leg ulcers. Phase II randomised-controlled study

    Page :228-232

    T. Baltazard, P. Senet, D. Momar, C. Picard, C. Joachim, A. Adas, C. Lok, G. Chaby

    Résumé Résumé Plan Plan  
  • ·Value of Doppler ultrasound scans in deciding whether to treat infantile haemangioma with oral propranolol

    Page :233-237

    C. Börjesson, J. Malloizel-Delaunay, G. Onnis, J. Mazereeuw-Hautier, I. Dreyfus

    Résumé Résumé Plan Plan   
  • ·Minors are the most affected by Chlamydia trachomatis in Reunion Island: A cross-sectional study, 2017–2018

    Page :238-240

    M. Folio, N. Bouscaren, B. De Barbeyrac, M.C. Boukerrou, C. Ricaud, S. Hoang, C. Levin, P. Poubeau, P. Gerardin, A. Bertolotti

    Résumé Résumé Plan Plan  
  • ·The keystone flap and its simplified version for malignant skin tumor defects of the lower limbs: A review of 25 cases

    Page :241-245

    A. Le Guern, T. Wiart, P. Modiano, D. Lebas

    Résumé Résumé Plan Plan  

• Letters

  • ·Development and co-construction of a therapeutic patient education program for albinism

    Page :246-250

    H. Dufresne, A. de Longcamp, S. Compain, F. Morice-Picard, E. Deladrière, L. Bekel, C. Godot, M. Rateaux, M. Godeau, B. Jouanne, C. Bodemer, D. Bremond-Gignac, M.P. Robert, S. Hadj-Rabia

    Résumé Résumé Plan Plan   
  • ·Teledermatology: The perspective of French general practitioners

    Page :251-252

    C. Skayem, H. Rostom, G. Hirsch, T.-A. Duong

    Plan Plan
  • ·Risk factors associated with recurrence of leg erysipelas in Togo

    Page :253-255

    P. Kassang, A.S. Akakpo, J.N. Téclessou, B. Esso, G. Mahamadou, A. Mouhari-Toure, K. Kombaté, K. Tchangai-Walla, P. Pitché, B. Saka

    Plan Plan  
  • ·Is it safe to vaccinate within a tattoo?

    Page :256-258

    N. Kluger

    Plan Plan  
  • ·Cosmetics used in children in sub-Saharan Africa and the desire for a lighter skin tone

    Page :259-261

    A.-S. Akakpo, J.N. Téclessou, D.A.E. Akolly, F.A. Gbeasor-Komlanvi, P. Kassang, A. Mouhari-Toure, K. Kombaté, B. Saka, P. Pitché

    Plan Plan
  • ·Omalizumab in chronic inducible urticaria: A retrospective, real-life study

    Page :262-265

    M. Fialek, F. Dezoteux, A. Le Moing, E. Karimova, N. Ramdane, E. Pape, S. Azib-Meftah, D. Staumont-Sallé

    Plan Plan  
  • ·A real-life assessment of the management of chronic urticaria in primary care by general practitioners in the North of France

    Page :266-268

    F. Dezoteux, B. Adam, E. Pape, S. Azib-Meftah, M. Calafiore, D. Staumont-Sallé

    Plan Plan  
  • ·Omalizumab in cold urticaria in children: Retrospective case series of 13 patients, review of the literature

    Page :269-271

    C. Briand, F. Tetart, A. Soria, D. Staumont-Sallé, B. Sterling, F. Boralevi, F. Castelain Lakkis, A. Du-Thanh, N. Raison-Peyron, C. Chiaverini

    Plan Plan
  • ·Intralesional rituximab treatment for atypical refractory granuloma faciale

    Page :272-274

    E. Joly, A. Duval-Modeste, R. Sabatier, G. Arhant, L. Cellier, M. Mouthon, F. Comoz, P. Joly, A. Dompmartin

    Plan Plan  
  • ·Mycosis fungoides in patients with multiple sclerosis: A report of two cases

    Page :275-277

    M. Donzel, B. Balme, S. Dalle

    Plan Plan